ADVERTISEMENT
 |
|
|
Top Stories
Bayer completed its acquisition of Monsanto, the largest in Bayer's history.
/ read more /
The companies will partner in research for HIV and hepatitis B immunotherapies, and Hookipa will manufacture arenavirus-based vectors for clinical development by Gilead.
/ read more /
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
|
Industry News
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.
/ read more /
Researchers at the National Cancer Institute have developed a new approach to immunotherapy that led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
/ read more /
More Industry News
|
|
|
|
Biopharma News
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
/ read more /
WuXi Biologics will invest $60 million to establish a biologics production facility in Massachusetts.
/ read more /
More Biopharma News
|
|
|
|
|
ADVERTISEMENT
Get Enhanced Detection and Reduce Your Analytical Burden
This new webinar highlights how to implement a complete an easy-to-use Multi-Attribute Methodology (MAM) workflow for biotherapeutic PQA monitoring using accurate mass LC-MS. It demonstrates a streamlined MAM workflow that can be used to track known impurities and identify new impurities using a single software. Plus, you will learn how to reduce your analytical testing burden by incorporating LC-MS into the development process.
 Learn More
|
|
|
|
Supplier News
Cambrex expands its generic API research and development capabilities at its Milan, Italy site.
/ read more /
Siemens will become a preferred supplier for Sartorius Stedim Biotech's automation solutions, and SSB will create a globally standardized automation platform for its biopharmaceutical manufacturing systems.
/ read more /
More Supplier News
|
|
|
Regulatory News
FDA and Congress seek to limit the production and distribution of pain medicines.
/ read more /
FDA Commissioner Scott Gottlieb, MD, released a statement on new agency efforts to involve the patient voice in medical product development and FDA regulatory decision-making.
/ read more /
More Regulatory News
|
|
|
|
|
SUPPLY CHAIN/LOGISTICS
Logistics manufacturers are adapting to explosive growth in the use of direct-to-patient clinical trials. Michael Sweeney, director of patient-centric logistics at World Courier Group, discusses the new model's impact.
/ read more /
|
|
|
Events
June 20–21, 2018
June 26, 2018
July 9–10, 2018
more events
|
|
|
eBook
|
How are contract development and manufacturing contract service organizations meeting the development and manufacturing needs of innovator biopharmaceuticals and biosimilars companies? In this BioPharm International ebook, the editors examine trends, partnerships, manufacturing capacity, regulatory, supply chain, and technical expertise issues.
|
|
|
|
|
|
